COVID-19 studies for: C19 studies:  HC QHC Q Vitamin DVitamin D IvermectinIVM LY-CoVLY REGN-COV2REGN RemdesivirRMD
HC Q study #136
Source   PDF   Share   Tweet
See all 143 studies
10/1
Positive
Late treatment study
Almazrou et al., Saudi Pharmaceutical Journal, doi:10.1016/j.jsps.2020.09.019 (Peer Reviewed)
Comparing the impact of Hydroxych loroquine based regimens and standard treatment on COVID-19 patient outcomes: A retrospective cohort study
Retrospective 161 hospitalized patients in Saudi Arabia showing lower ventilation and ICU admission with HC Q, but not statistically significant with the small sample sizes.
ventilation, ↓65.0%, p=0.16
ICU admission, ↓21.0%, p=0.78
Source   PDF   Share   Tweet
See all 143 studies
Please send us corrections, updates, or comments.
Submit